These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


509 related items for PubMed ID: 28288894

  • 1. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis.
    Alam MM, Han HS, Sung S, Kang JH, Sa KH, Al Faruque H, Hong J, Nam EJ, Kim IS, Park JH, Kang YM.
    J Control Release; 2017 Apr 28; 252():62-72. PubMed ID: 28288894
    [Abstract] [Full Text] [Related]

  • 2. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS, Lee J, Kim HR, Chae SY, Kim M, Saravanakumar G, Yoon HY, You DG, Ko H, Kim K, Kwon IC, Park JC, Park JH.
    J Control Release; 2013 Jun 10; 168(2):105-14. PubMed ID: 23474029
    [Abstract] [Full Text] [Related]

  • 3. Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis.
    Zhao J, Zhang X, Sun X, Zhao M, Yu C, Lee RJ, Sun F, Zhou Y, Li Y, Teng L.
    Eur J Pharm Biopharm; 2018 Sep 10; 130():39-47. PubMed ID: 29928978
    [Abstract] [Full Text] [Related]

  • 4. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
    Pandey S, Kumar V, Leekha A, Rai N, Ahmad FJ, Verma AK, Talegaonkar S.
    Pharm Res; 2018 Sep 05; 35(11):201. PubMed ID: 30187188
    [Abstract] [Full Text] [Related]

  • 5. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.
    Zhao J, Zhao M, Yu C, Zhang X, Liu J, Cheng X, Lee RJ, Sun F, Teng L, Li Y.
    Int J Nanomedicine; 2017 Sep 05; 12():6735-6746. PubMed ID: 28932117
    [Abstract] [Full Text] [Related]

  • 6. Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis.
    Pandey S, Rai N, Mahtab A, Mittal D, Ahmad FJ, Sandal N, Neupane YR, Verma AK, Talegaonkar S.
    Int J Biol Macromol; 2021 Feb 28; 171():502-513. PubMed ID: 33422513
    [Abstract] [Full Text] [Related]

  • 7. Hyaluronic acid-coated solid lipid nanoparticles enhance antirheumatic activity and reduce toxicity of methotrexate.
    Mirchandani Y, Patravale VB, Brijesh S.
    Nanomedicine (Lond); 2022 Jul 28; 17(16):1099-1114. PubMed ID: 36178114
    [Abstract] [Full Text] [Related]

  • 8. Prolonged, staged, and self-regulated methotrexate release coupled with ROS scavenging in an injectable hydrogel for rheumatoid arthritis therapy.
    Xu M, Fu T, Zhang C, An Z, Yan J, Lu Z, Wu H, Liu J, Qiu L, Shi L, Lin J, Cao Y, Pei R.
    J Control Release; 2024 Nov 28; 375():60-73. PubMed ID: 39216600
    [Abstract] [Full Text] [Related]

  • 9. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
    Tamura T, Higuchi Y, Kitamura H, Murao N, Saitoh R, Morikawa T, Sato H.
    Arthritis Res Ther; 2016 Apr 01; 18():79. PubMed ID: 27039182
    [Abstract] [Full Text] [Related]

  • 10. Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery.
    Yoon HY, Koo H, Choi KY, Chan Kwon I, Choi K, Park JH, Kim K.
    Biomaterials; 2013 Jul 01; 34(21):5273-80. PubMed ID: 23591396
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surface saturation of drug-loaded hollow manganese dioxide nanoparticles with human serum albumin for treating rheumatoid arthritis.
    Jia M, Ren W, Wang M, Liu Y, Wang C, Zhang Z, Xu M, Ding N, Li C, Yang H.
    Drug Deliv; 2024 Dec 01; 31(1):2380538. PubMed ID: 39044468
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Redox Sensitive Shell and Core Crosslinked Hyaluronic Acid Nanocarriers for Tumor-Targeted Drug Delivery.
    Zheng H, Yin L, Zhang X, Zhang H, Hu R, Yin Y, Qiu T, Xiong X, Wang Q.
    J Biomed Nanotechnol; 2016 Aug 01; 12(8):1641-53. PubMed ID: 29342343
    [Abstract] [Full Text] [Related]

  • 20. Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis.
    Heo R, You DG, Um W, Choi KY, Jeon S, Park JS, Choi Y, Kwon S, Kim K, Kwon IC, Jo DG, Kang YM, Park JH.
    Biomaterials; 2017 Jul 01; 131():15-26. PubMed ID: 28371624
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.